Chicago, Illinois, United States | Fund Name | Location |
| Boston Meridian Partners | California, San Francisco, United States |
| Kiva | California, San Francisco, United States |
| Phi Capital | Delhi, India, New Delhi |
| Royal Luck Fund | Beijing, Beijing, China |
| Shinobi Capital | - |
| SmartCapital | Castile and León, Salamanca, Spain |
| SWK Holdings Corporation | Dallas, Texas, United States |
| Venture Law Group | Alberta, Canada, Edmonton |
| Yamaha Motor Co., | Iwata, Japan, Shizuoka Prefecture |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Nest Health | $15M | 23 Mar 2023 | New Orleans, Louisiana, United States | ||
Onc.AI | $25M | 05 Jan 2023 | California, United States | ||
Limber | $11M | 20 Oct 2022 | Washington, District of Columbia, United States | ||
Upward Health | 13 Sep 2022 | Providence, Rhode Island, United States | |||
Abacus Insights | $28M | 16 Jun 2022 | New York, New York, United States | ||
Waltz Health | $35M | 26 Apr 2022 | Chicago, Illinois, United States | ||
CirrusMD | $20M | 31 Mar 2021 | Denver, Colorado, United States | ||
Lumiata | $14M | 14 Jan 2021 | California, United States |
– Drips secured a growth investment from the Blue Venture Fund to support the company’s vision of enabling healthcare organizations to connect with their members and patients during critical moments through its conversational AI platform.
– This investment follows the previously announced investment from leading software investor Accel-KKR and its credit facility with Wells Fargo Capital Finance’s Technology Finance group.
– Ultromics, an Oxford, UK-based company focused on advancing AI enabled cardiovascular imaging solutions, raised $33M in series B funding.
– The round was led by Blue Venture Fund with participation from Optum Ventures, GV and Oxford Sciences Innovation.
– The new investment will be aimed at accelerating the use of AI-enabled echocardiograms to improve patient care, and bring improved diagnostic quality and resource savings to hospitals.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Octave Bioscience | $32M | 26 Jul 2023 | California, United States | ||
Nest Health | $15M | 23 Mar 2023 | New Orleans, Louisiana, United States | ||
Onc.AI | $25M | 05 Jan 2023 | California, United States | ||
Limber | $11M | 20 Oct 2022 | Washington, District of Columbia, United States | ||
Upward Health | 13 Sep 2022 | Providence, Rhode Island, United States | |||
Abacus Insights | $28M | 16 Jun 2022 | New York, New York, United States | ||
Waltz Health | $35M | 26 Apr 2022 | Chicago, Illinois, United States | ||
CirrusMD | $20M | 31 Mar 2021 | Denver, Colorado, United States | ||
Lumiata | $14M | 14 Jan 2021 | California, United States |
